HealthData.Gov
The Meeting Abstracts database contains selected abstracts from meetings and conferences in the subject areas of: AIDS, Health Services Research, and Space Life Sciences, published between 1990 – 2010. The abstracts are…
HealthData.Gov
US weekly Nationally Notifiable Disease Surveillance Data from 1888 to 2013. These data include tables of disease counts reported by US states and cities to the Federal Health Authorities every week since 1888. These…
HealthData.Gov
The Medicare Current Beneficiary Survey (MCBS) - Cost Supplement File Microdata Public Use File (PUF) dataset provides information on expenditures and payment sources for all services used by Medicare beneficiaries,…
HealthData.Gov
The drug labels and other drug-specific information on this Web site represent the most recent drug listing information companies have submitted to the Food and Drug Administration (FDA). (See 21 CFR part 207.) The drug…
HealthData.Gov
The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared, propagated, compounded, or processed by it…
HealthData.Gov
Medical device manufacturers are required to submit a premarket notification or 510(k) if they intend to introduce a device into commercial distribution for the first time or reintroduce a device that will be…
HealthData.Gov
The publication Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book) identifies drug products approved on the basis of safety and effectiveness by the Food and…
HealthData.Gov
The FDA Adverse Event Reporting System (FAERS) is a database that contains information on adverse event and medication error reports submitted to FDA. The database is designed to support the FDA's post-marketing safety…
HealthData.Gov
The FDA Acronyms and Abbreviations database provides a quick reference to acronyms and abbreviations related to Food and Drug Administration (FDA) activities
HealthData.Gov
Provides information to the public on postmarket requirements and commitments. The phrase postmarket requirements and commitments refers to studies and clinical trials that sponsors conduct after approval to gather…
HealthData.Gov
The Adverse Event Reporting System (AERS) is a computerized information database designed to support the FDA's post-marketing safety surveillance program for all approved drug and therapeutic biologic products. The FDA…